Because the TATA/TATA genotype causes low LMO1 expression and LMO1 is required for the adrenergic CRC to form, we predict that the TATA/TATA genotype would protect against neuroblastoma in patients with germline activating mutations of PHOX2B (46, 47). The gene discussed is LMO1; the disease is neuroblastoma.